Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy

Abstract The purpose of this study was to investigate whether baseline neutrophil to lymphocyte ratio (NLR) was an independent predictor for early symptomatic intracranial hemorrhage (sICH), poor functional outcome and mortality at 3 months after reperfusion therapy in acute ischemic stroke (AIS) pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ying Bi, Jing Shen, Sheng-Cai Chen, Ji-Xiang Chen, Yuan-Peng Xia
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/37b65002ac8349dc8b1b7da91a47f00f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:37b65002ac8349dc8b1b7da91a47f00f
record_format dspace
spelling oai:doaj.org-article:37b65002ac8349dc8b1b7da91a47f00f2021-12-02T17:05:11ZPrognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy10.1038/s41598-021-85373-52045-2322https://doaj.org/article/37b65002ac8349dc8b1b7da91a47f00f2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85373-5https://doaj.org/toc/2045-2322Abstract The purpose of this study was to investigate whether baseline neutrophil to lymphocyte ratio (NLR) was an independent predictor for early symptomatic intracranial hemorrhage (sICH), poor functional outcome and mortality at 3 months after reperfusion therapy in acute ischemic stroke (AIS) patients. Using PubMed and EMBASE, we searched for literature published before January 19th, 2019. Two reviewers independently confirmed each study’s eligibility, assessed risk of bias, and extracted data. One reviewer combined studies using random effects meta-analysis. 9 studies with 3651 patients were pooled in the meta-analysis. Overall, baseline NLR levels were greater in patients with poor outcome. The standardized mean difference (SMD) in the NLR levels between patients with poor functional outcome (mRS > 2) and good functional outcome (mRS ≤ 2) was 0.54 units (95% credible interval [CI] [0.38, 0.70]). Heterogeneity test showed that there were significant differences between individual studies (p = 0.02; I2 = 72.8%). The NLR levels were associated with sICH in four included studies (n = 2003, SMD = 0.78, 95% [CI] [0.18, 1.38], I2 = 73.9%). Higher NLR levels were positively correlated with 3-month mortality (n = 1389, ES = 1.71, 95% CI [1.01,2.42], p < 0.01, I2 = 0%) when data were used as categorical variables. Our meta-analysis suggests that increased NLR levels are positively associated with greater risk of sICH, 3-month poor functional outcome and 3-month mortality in AIS patients undergoing reperfusion treatments. Although there are some deficits in this study, it may be feasible to predict the prognosis of reperfusion therapy in AIS patients with NLR levels.Ying BiJing ShenSheng-Cai ChenJi-Xiang ChenYuan-Peng XiaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ying Bi
Jing Shen
Sheng-Cai Chen
Ji-Xiang Chen
Yuan-Peng Xia
Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
description Abstract The purpose of this study was to investigate whether baseline neutrophil to lymphocyte ratio (NLR) was an independent predictor for early symptomatic intracranial hemorrhage (sICH), poor functional outcome and mortality at 3 months after reperfusion therapy in acute ischemic stroke (AIS) patients. Using PubMed and EMBASE, we searched for literature published before January 19th, 2019. Two reviewers independently confirmed each study’s eligibility, assessed risk of bias, and extracted data. One reviewer combined studies using random effects meta-analysis. 9 studies with 3651 patients were pooled in the meta-analysis. Overall, baseline NLR levels were greater in patients with poor outcome. The standardized mean difference (SMD) in the NLR levels between patients with poor functional outcome (mRS > 2) and good functional outcome (mRS ≤ 2) was 0.54 units (95% credible interval [CI] [0.38, 0.70]). Heterogeneity test showed that there were significant differences between individual studies (p = 0.02; I2 = 72.8%). The NLR levels were associated with sICH in four included studies (n = 2003, SMD = 0.78, 95% [CI] [0.18, 1.38], I2 = 73.9%). Higher NLR levels were positively correlated with 3-month mortality (n = 1389, ES = 1.71, 95% CI [1.01,2.42], p < 0.01, I2 = 0%) when data were used as categorical variables. Our meta-analysis suggests that increased NLR levels are positively associated with greater risk of sICH, 3-month poor functional outcome and 3-month mortality in AIS patients undergoing reperfusion treatments. Although there are some deficits in this study, it may be feasible to predict the prognosis of reperfusion therapy in AIS patients with NLR levels.
format article
author Ying Bi
Jing Shen
Sheng-Cai Chen
Ji-Xiang Chen
Yuan-Peng Xia
author_facet Ying Bi
Jing Shen
Sheng-Cai Chen
Ji-Xiang Chen
Yuan-Peng Xia
author_sort Ying Bi
title Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
title_short Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
title_full Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
title_fullStr Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
title_full_unstemmed Prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
title_sort prognostic value of neutrophil to lymphocyte ratio in acute ischemic stroke after reperfusion therapy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/37b65002ac8349dc8b1b7da91a47f00f
work_keys_str_mv AT yingbi prognosticvalueofneutrophiltolymphocyteratioinacuteischemicstrokeafterreperfusiontherapy
AT jingshen prognosticvalueofneutrophiltolymphocyteratioinacuteischemicstrokeafterreperfusiontherapy
AT shengcaichen prognosticvalueofneutrophiltolymphocyteratioinacuteischemicstrokeafterreperfusiontherapy
AT jixiangchen prognosticvalueofneutrophiltolymphocyteratioinacuteischemicstrokeafterreperfusiontherapy
AT yuanpengxia prognosticvalueofneutrophiltolymphocyteratioinacuteischemicstrokeafterreperfusiontherapy
_version_ 1718381784826118144